<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.28225.2</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Human Proteinase 3, an important autoantigen of c-ANCA associated vasculitis, shares cross-reactive epitopes with serine protease allergens from mites: an
                    <italic> in silico </italic>analysis</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 2; peer review: 1 approved, 2 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Buend&#x00ed;a</surname>
                        <given-names>Emiro</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-4853-336X</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Marlon</surname>
                        <given-names>M&#x00fa;nera</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-3428-0541</uri>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Parra</surname>
                        <given-names>Orlando</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>S&#x00e1;nchez</surname>
                        <given-names>Mar&#x00ed;a</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>S&#x00e1;nchez</surname>
                        <given-names>Andr&#x00e9;s</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>S&#x00e1;nchez</surname>
                        <given-names>Jorge</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Viasus</surname>
                        <given-names>Diego</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Internal Medicine, Universidad del Norte, Barranquilla, Atlantico, 080004, Colombia</aff>
                <aff id="a2">
                    <label>2</label>Division of Health Sciences, Universidad del Norte, Barranquilla, Atlantico, 080004, Colombia</aff>
                <aff id="a3">
                    <label>3</label>Faculty of Medicine, Universidad de Cartagena, Cartagena, Colombia</aff>
                <aff id="a4">
                    <label>4</label>Medical Research group (GINUMED), Universitary Corporation Rafael N&#x00fa;&#x00f1;ez, Cartagena, Bol&#x00ed;var, 130001, Colombia</aff>
                <aff id="a5">
                    <label>5</label>Department of Internal Medicine, Universidad El Bosque, Bogot&#x00e1;, Cundinamarca, 110111, Colombia</aff>
                <aff id="a6">
                    <label>6</label>Departement of Pediatrics, Universidad de Cartagena, Cartagena, Bol&#x00ed;var, 130001, Colombia</aff>
                <aff id="a7">
                    <label>7</label>Group of Clinical and Experimental Allergy (GACE), IPS Universitaria, Universidad de Antioquia, Medell&#x00ed;n, Antioquia, 050001, Colombia</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:erbuendia@uninorte.edu.co">erbuendia@uninorte.edu.co</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>3</day>
                <month>2</month>
                <year>2022</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2021</year>
            </pub-date>
            <volume>10</volume>
            <elocation-id>47</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>1</day>
                    <month>2</month>
                    <year>2022</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Buend&#x00ed;a E et al.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/10-47/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> In autoimmune vasculitis, autoantibodies to Human Proteinase 3 (PR3), a human serine protease, seems to have a role on the inception of c-ANCA associated vasculitis. The origin of this autoreactive response remains unclear. However, for several autoreactive responses, molecular mimicry between environmental antigens and human proteins is key in triggering autoantibodies and finally autoimmunity manifestations. Therefore, considering that PR3 is a serine protease and house dust mite (HDM) group 3 allergens share this biochemical activity, the aim of this study was to identify cross-reactive epitopes between serine proteases from human and mites using an 
                    <italic toggle="yes">in silico</italic> approach.</p>
                <p>
                    <bold>Methods:</bold> Multi alignment among amino acid sequences of PR3 and HDM group 3 allergens was performed to explore identity and structural homology. The ElliPro and BepiPred 
                    <italic toggle="yes">in silico</italic> tools were used to predict B and T cell epitopes. The Consurf tool was used to conduct identification of conserved regions in serine proteases family.</p>
                <p>
                    <bold>Results:</bold> PR3 and HDM group 3 allergens shared moderate identity and structural homology (root mean square deviation &lt; 1). One B cell cross reactive epitope among serine proteases was identified (29I, 30V, 31G, 32G, 34E, 36K, 37A, 38L, 39A and 54C) and two T cell epitopes.</p>
                <p>
                    <bold>Conclusions:</bold> PR3 have structural homology and share cross reactive epitopes with HDM group 3 allergens.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Serine proteases</kwd>
                <kwd>human proteinase 3</kwd>
                <kwd>house dust mites group 3 allergens</kwd>
                <kwd>ANCA associated vasculitis</kwd>
                <kwd>sequence homology</kwd>
                <kwd>T and B cell epitopes</kwd>
                <kwd>cross-reactivity</kwd>
                <kwd>epitope modelling</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>Fondo Nacional de Financiamiento para la Ciencia, la Tecnolog&#x00ed;a y la Innovaci&#x00f3;n</funding-source>
                    <award-id>80740-249-2020</award-id>
                </award-group>
                <funding-statement>Buend&#x00ed;a, E. received a postdoctoral grant (Fondo Nacional de Financiamiento para la Ciencia, la Tecnolog&#x00ed;a y la Innovaci&#x00f3;n "FRANCISCO JOS&#x00c9; DE CALDAS") from Ministerio de Ciencia, Tecnolog&#x00ed;a e Innovaci&#x00f3;n, Colombia (grant number 80740-249-2020).</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
        <notes>
            <sec sec-type="version-changes">
                <label>Revised</label>
                <title>Amendments from Version 1</title>
                <p>The manuscript was revised and refined by a language style corrector. Some sentences in the methods and results section were improved giving more detail and explanations in accord to revisor suggestions.</p>
            </sec>
        </notes>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p>Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a life-threatening autoimmune disease affecting small vessels, compromising the respiratory mucosa, skin, lung, and the kidney
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. This group of small vessel vasculitis includes various diseases: granulomatosis with polyangiitis, microscopic polyangiitis, kidney-limited vasculitis and Eosinophilic granulomatosis with polyangiitis, all of them having in common some degree of autoimmune response to the Human Proteinase 3 protein (PR3). Previous studies have shown that autoantibody binding to PR3 expressed on the neutrophil surface may activate its degranulation, eliciting tissue damage in small vessels and their irrigated organs. Also, while proinflammatory effector T cells have been implicated in vasculitis pathogenesis
                <sup>
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>, a specific PR3 T cell epitope has not been reported in AAV patients
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. PR3 is a serine protease physiologically expressed in human neutrophils. Due to its enzymatic activity, it degrades various intercellular gap-junction proteins and collagen and may play a role in neutrophil transendothelial migration. In addition, this protein is an important autoantigen in AAV, and sera from patients with severe and relapsing forms of the disease can bind it in IgG ELISA assays
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>. Further, although a cause-effect relationship between PR3-autoantibodies and vasculitis is not clearly defined, animal models support a pathogenic role
                <sup>
                    <xref ref-type="bibr" rid="ref-7">7</xref>,
                    <xref ref-type="bibr" rid="ref-8">8</xref>
                </sup>, revealing that they may be involved in disease inception, progression and severity
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>.</p>
            <p>Environmental exposures, specially to microbial components mimicking self-antigens have been proposed as triggers of autoimmunity
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>,
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>. Also, in AAV, it has been proposed that an endogenous immune response to a complementary protein to PR3 autoantigen could be implicated in disease inception, and this antisense protein harbors homology to various bacterial peptides
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup>. PR3 crystal structure has been elucidated, and various epitopes are recognized by patients suffering AAV; however, its cross-reactivity with environmental antigens is poorly studied
                <sup>
                    <xref ref-type="bibr" rid="ref-12">12</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-14">14</xref>
                </sup>.</p>
            <p>Previous studies have shown that specific IgE to some self-proteins have been identified in autoimmune and allergic diseases like lupus, urticaria, dermatitis, allergic pulmonary aspergillosis and have a strong association with disease activity
                <sup>
                    <xref ref-type="bibr" rid="ref-15">15</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-18">18</xref>
                </sup>. Some allergens can cross-react with human proteins and participates in autoimmunity inception in pemphigus vulgaris by a &#x201c;hit-and-run&#x201d; mechanism, opening the theoretical possibility for a similar mechanism to occur in another autoimmune disease such as AAV
                <sup>
                    <xref ref-type="bibr" rid="ref-19">19</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-22">22</xref>
                </sup>.</p>
            <p>In the tropics, house dust mites (HDM) are important ubiquitous allergen sources and exposure is perennial, increasing the possibilities of exposure in the general population
                <sup>
                    <xref ref-type="bibr" rid="ref-23">23</xref>
                </sup>, and IgE sensitization to their components
                <sup>
                    <xref ref-type="bibr" rid="ref-24">24</xref>,
                    <xref ref-type="bibr" rid="ref-25">25</xref>
                </sup>. Sensitization to HDM group 3 allergens is common
                <sup>
                    <xref ref-type="bibr" rid="ref-26">26</xref>
                </sup>, as they harbor serine protease activity and conserved structural homology
                <sup>
                    <xref ref-type="bibr" rid="ref-27">27</xref>
                </sup>, making them potential PR3 cross reactive antigens; this has not been explored before. Here, we show 
                <italic toggle="yes">in silico</italic> data suggesting cross-reactivity and epitope sharing between PR3 and HDM group 3 allergens.</p>
        </sec>
        <sec sec-type="method">
            <title>Methods</title>
            <sec>
                <title>Searching homologous with BLAST (Basic Local Alignment Search Tool)</title>
                <p>The amino acid sequence from the human PR3 (Uniprot accession: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P24158">P24158</ext-link>) was used as query to perform a search for serine protease homologous reported in allergenic sources: 
                    <italic toggle="yes">Dermatophagoides pteronyssinus</italic> (Der p 3: Accession number 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P39675">P39675</ext-link>), 
                    <italic toggle="yes">Blomia tropicalis</italic> (Blo t 3: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/A1KXI1">A1KXI1</ext-link>), 
                    <italic toggle="yes">Glycyphagus domesticus</italic> (Gly d 3: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/Q1M2M8">Q1M2M8</ext-link>),  
                    <italic toggle="yes">Lepidoglyphus destructor</italic> (Led p 3: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/Q1M2L7">Q1M2L7</ext-link>) and 
                    <italic toggle="yes">Tyrophagus putrescentiae</italic> (Tyr p 3: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/C6ZDB5">C6ZDB5</ext-link>) with the 
                    <ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&quot;Proteins&quot;blastp&quot;on">PSI-BLAST</ext-link> tool. Parameters were set as default.</p>
            </sec>
            <sec>
                <title>Multiple alignment</title>
                <p>Identity among all allergenic sequences homologous to PR3 was analyzed using the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.jalview.org/">Jalview tool</ext-link>2.11.0
                    <sup>
                        <xref ref-type="bibr" rid="ref-28">28</xref>
                    </sup>. First, all allergens and human PR3 codes were used as inputs in the Jalview tool. Second, the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/tcoffee/">T coffee tool</ext-link> was chosen to assess alignment. Third, alignment was displayed as an identity percentage.</p>
            </sec>
            <sec>
                <title>Construction of 3D model</title>
                <p>The 3D model of Der p 3, a serine protease of 
                    <italic toggle="yes">Dermatophagoides pteronyssinus</italic> was generated by homology in the 
                    <ext-link ext-link-type="uri" xlink:href="https://swissmodel.expasy.org/">SWISS-MODEL</ext-link> server using the zymogen catalytic region of human MASP-2 (PDB: 1zjk f) as a template. The 3D model of Der p 3 was loaded into the ProSA-web server
                    <sup>
                        <xref ref-type="bibr" rid="ref-29">29</xref>
                    </sup>, which was used to analyze its quality.</p>
                <p>The model was refined in 
                    <ext-link ext-link-type="uri" xlink:href="https://spdbv.vital-it.ch/">DeepView</ext-link> v4.1 (energy minimization and rotamer replacements). Its quality was evaluated by several tools, including Ramachandran graphs, WHATIF, QMEAN4 index, and energy values (GROMOS96 force field). For the validation of the Der p 3 structure we used the Minimize Structure option in the UCSF Chimera software, a procedure that adjust the energy and reduce the entropy of the model
                    <sup>
                        <xref ref-type="bibr" rid="ref-30">30</xref>
                    </sup>.</p>
                <p>Three-dimensional structure (PDB: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1FUJ">1FUJ</ext-link>) of the human PR3 serine protease was retrieved from the Protein Data Bank. A cartoon model was created using 
                    <ext-link ext-link-type="uri" xlink:href="https://pymol.org/2/">Pymol software</ext-link> v2.4. Root median square deviation (RMSD) value between Der p 3 and PR3 was calculated using 
                    <ext-link ext-link-type="uri" xlink:href="https://www.cgl.ucsf.edu/chimera/download.html">Chimera software</ext-link> v1.0
                    <sup>
                        <xref ref-type="bibr" rid="ref-30">30</xref>
                    </sup>.</p>
            </sec>
            <sec>
                <title>B and T cell epitope prediction</title>
                <p>
                    <ext-link ext-link-type="uri" xlink:href="http://tools.iedb.org/ellipro/">ElliPro</ext-link> v3.0 and 
                    <ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/BepiPred/">BepiPred</ext-link> v2.0 tools were used to predict B and T cell epitopes on Der p 3
                    <sup>
                        <xref ref-type="bibr" rid="ref-31">31</xref>,
                        <xref ref-type="bibr" rid="ref-32">32</xref>
                    </sup>. With ElliPro, the 3D structure of Der p 3 was used to predict epitopes. Minimum score and maximum distance (Angstrom) were set to 0.5 and 6, respectively. Epitopes with high conserved rates were visualized in the 3D model. For prediction using BepiPred, an amino acid sequence of Der p 3 was used as input.</p>
            </sec>
            <sec>
                <title>Conservation analysis</title>
                <p>The 3D structure of Der p 3 was submitted to the 
                    <ext-link ext-link-type="uri" xlink:href="https://consurf.tau.ac.il/">ConSurf server</ext-link> to generate evolutionarily related conservation scores to help to identify functional regions in the proteins. HMMER algorithm, 1 iteration, E-value cutoff (0.0001) and UNIREF-90 database was set as default to generate multiple alignment, prior to evolutive analysis. All amino acid sequences in FASTA format were used.</p>
            </sec>
        </sec>
        <sec sec-type="results">
            <title>Results</title>
            <sec>
                <title>Human PR3 and HDM group 3 allergens exhibited identity and features of the serine protease family</title>
                <p>BLAST search identified various serine protease family members from HDM as homologous. The multiple sequence alignment analysis showed that Der p 3, Blo t 3, Gly d 3, Led p 3 and Tyr p 3 allergens shared 45% of identity in their aminoacid sequences with PR3. The most conserved region is located between residues 53 to 75, indicating the existence of molecular mimicry (
                    <xref ref-type="fig" rid="f1">Figure 1</xref>). Among the members of HDM group 3 allergens, an identity until 41% was reported (
                    <xref ref-type="table" rid="T1">Table 1</xref>), and a highly conserved region between residues 40 to 90 was found. When identity between PR3 and each allergen used in study was analyzed, a moderate level of identity was found (30%) (
                    <xref ref-type="table" rid="T1">Table 1</xref>).</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Multiple alignment among PR3 and the HDM allergens belonging to group 3.</title>
                        <p>An identity of 45% in their amino acid sequences was found.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/81402/55ca4252-38be-4564-9d89-b128f4bb8094_figure1.gif"/>
                </fig>
                <table-wrap id="T1" orientation="portrait" position="anchor">
                    <label>Table 1. </label>
                    <caption>
                        <title>Identity matrix among serine proteases used in study.</title>
                        <p>All comparisons of PR3 with HDM group 3 allergens showed a moderate identity.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1"/>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>PR3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Der p 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Blo t 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Gly d 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Lep d 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Tyr p 3</bold>
                                </td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>PR3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FA8F72">33</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F8696B">27</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F97C6E">30</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F97C6E">30</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F8696B">27</td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Der p 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FA8F72">33</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FEEB84">48</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F2E884">52</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#EFE784">53</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FDCE7E">43</td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Blo t 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F8696B">27</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FEEB84">48</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#E0E383">58</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#E0E383">58</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FEE783">47</td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Gly d 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F97C6E">30</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F2E884">52</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#E0E383">58</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#66BF7C">99</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FCC17C">41</td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Lep d 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F97C6E">30</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#EFE784">53</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#E0E383">58</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#66BF7C">99</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FCC17C">41</td>
                            </tr>
                            <tr>
                                <td align="center" colspan="1" rowspan="1">
                                    <bold>Tyr p 3</bold>
                                </td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#F8696B">27</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FDCE7E">43</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FEE783">47</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FCC17C">41</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#FCC17C">41</td>
                                <td align="center" colspan="1" rowspan="1" style="background-color:#63BE7B">100</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>A structural model of Der p 3 was obtained by homology modelling using the 3D structure of PR3 reported in the PDB database. According to modelling, the Der p 3 tertiary structure exhibited a typical fold of serine protease family, conformed by four &#x03b1;-helixes and fifteen &#x03b2;-strands with structural homology with PR3 (RMSD = 0.8) (
                    <xref ref-type="fig" rid="f2">Figure 2</xref>). </p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>Cartoon models of PR3 and Der p 3.</title>
                        <p>(
                            <bold>A</bold>) PR3; (
                            <bold>B</bold>) Der p 3. According to modelling by homology, Der p 3 exhibited a typical fold of serine protease family. (
                            <bold>C</bold>) Overlapping of 3D model of PR3 and Der p 3. RMSD value of 0.8 is reported, suggesting structural homology.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/81402/55ca4252-38be-4564-9d89-b128f4bb8094_figure2.gif"/>
                </fig>
            </sec>
            <sec>
                <title>T and B cell cross-reactive epitopes were predicted between HDM group 3 allergens and PR3</title>
                <p>Using ElliPro and BepiPred servers, a cross reactive B cell epitope was predicted on all serine protease used in this study. This epitope is formed by ten residues and is on the N-terminal region, spanning amino acids 29 and 39 with a surface area of 470 &#x00c5;, not forming part of any domain within the protein. Conservative analysis indicated that the antigenic region predicted was highly conserved in the serine proteases (
                    <xref ref-type="fig" rid="f3">Figure 3</xref>).  According to ConSurf analysis, the region covering the cross-reactive epitope is conserved among the serine protease family (
                    <xref ref-type="fig" rid="f4">Figure 4</xref>). T cell epitope prediction identified at least two epitopes with potential cross-reactivity among all sequences analyzed. Both epitopes are located on the first and second &#x03b2; strands: the first epitope spans the 45 to 59 region (ISLQSSSHFCGGTIL); and the second, the 63 to 77 region (WILTAAHCVAGQTAS) (
                    <xref ref-type="fig" rid="f5">Figure 5</xref>; 
                    <xref ref-type="table" rid="T2">Table 2</xref>).</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <p>(
                            <bold>A</bold>) Surface model of Der p 3, showing area occupied by B cell epitope predicted as cross reactive. (
                            <bold>B</bold>) Cartoon model showing location of epitope on tridimensional structure. It can be appreciated that the predicted epitope is on a loop spanning residues 29 to 39.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/81402/55ca4252-38be-4564-9d89-b128f4bb8094_figure3.gif"/>
                </fig>
                <fig fig-type="figure" id="f4" orientation="portrait" position="float">
                    <label>Figure 4. </label>
                    <caption>
                        <title>Phylogenetic analysis of the serine proteases using Consurf.</title>
                        <p>(
                            <bold>A</bold> and 
                            <bold>C</bold>) Cartoon models showing the conserved region among serine proteases. (
                            <bold>B</bold> and 
                            <bold>D</bold>) Surface models showing the conserved region among serine proteases.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/81402/55ca4252-38be-4564-9d89-b128f4bb8094_figure4.gif"/>
                </fig>
                <fig fig-type="figure" id="f5" orientation="portrait" position="float">
                    <label>Figure 5. </label>
                    <caption>
                        <title>Cartoon model showing the location of T cell epitopes in their tridimensional structure.</title>
                        <p>It can be appreciated that predicted epitopes are in a continuous &#x03b2; strands (blue and magenta).</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/81402/55ca4252-38be-4564-9d89-b128f4bb8094_figure5.gif"/>
                </fig>
                <table-wrap id="T2" orientation="portrait" position="anchor">
                    <label>Table 2. </label>
                    <caption>
                        <title>T cell epitopes predicted 
                            <italic toggle="yes">in silico</italic>.</title>
                        <p>Both are conserved among PR3 and HDM group 3 allergens.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1">Allele</th>
                                <th align="left" colspan="1" rowspan="1">Start</th>
                                <th align="left" colspan="1" rowspan="1">End</th>
                                <th align="left" colspan="1" rowspan="1">Sequence</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">HLA-DRB1*01:01</td>
                                <td align="left" colspan="1" rowspan="1">45</td>
                                <td align="left" colspan="1" rowspan="1">59</td>
                                <td align="left" colspan="1" rowspan="1">ISLQSSSHFCGGTIL</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1">HLA-DRB1*01:01</td>
                                <td align="left" colspan="1" rowspan="1">63</td>
                                <td align="left" colspan="1" rowspan="1">77</td>
                                <td align="left" colspan="1" rowspan="1">WILTAAHCVAGQTAS</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
        </sec>
        <sec sec-type="discussion">
            <title>Discussion</title>
            <p>In this study we found that PR3 and HDM group 3 serine protease allergens have conserved identity and homology. Also, for the first time, we predicted various T and B cell cross reactive epitopes between them through an 
                <italic toggle="yes">in silico</italic> approach. PR3 is an important autoantigen in small vessel vasculitis and it seems to participate in disease inception, progression, and severity
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. Our results have potential implications for the understanding of autoreactive response in AAV and open the possibility for a new environmental trigger of the autoreactive response in AAV.</p>
            <p>In AAV, it has been proposed that autoantibodies directed to a complementary protein to PR3 autoantigen could be implicated in disease inception, and this antisense protein harbors homology to various bacterial peptides
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup> &#x2013; a theory named autoantigen complementarity
                <sup>
                    <xref ref-type="bibr" rid="ref-33">33</xref>
                </sup>. However, in epidemiological studies, autoantigen complementarity hypothesis testing has showed conflicting results, since sera from some patients suffering from AAV do not recognize complementary PR3, while others do
                <sup>
                    <xref ref-type="bibr" rid="ref-34">34</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-36">36</xref>
                </sup>. Also, molecular mimicry of PR3 protein by infectious microorganism components have been proposed as a possible environmental trigger of the disease based on the reports of infections preceding the manifestations of vasculitis
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>,
                    <xref ref-type="bibr" rid="ref-37">37</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-39">39</xref>
                </sup>, although a cross reactive antigen have not been reported yet.</p>
            <p>In their seminal publication, Pendergraft 
                <italic toggle="yes">et al</italic>. run a BLAST query to find homologues of PR3 protein in microbial or fungal microorganisms, and do not find matching sequences at that time
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup>. However, they do not include Arachnida or other environmental sources of cross-reactivity. In our analysis we find matching PR3 protein sequences with various HDM group 3 serine protease allergens, and at least theoretically this finding could have many implications for the understanding of inception and even diagnosis of autoreactive response in AAV. Recently, Qian 
                <italic toggle="yes">et al</italic>. have shown that some allergens can cross-react with human proteins
                <sup>
                    <xref ref-type="bibr" rid="ref-19">19</xref>
                </sup> and participate in autoimmunity inception in pemphigus vulgaris by a &#x201c;hit-and-run&#x201d; mechanism
                <sup>
                    <xref ref-type="bibr" rid="ref-22">22</xref>
                </sup>, opening the theoretical possibility for a similar mechanism to occur in another autoimmune disease such as AAV. Similarly, in atopic dermatitis, Valenta and collaborators observe that some patients with severe complications from the disease, had IgE directed to the profilin of the 
                <italic toggle="yes">Betula verrucosa</italic>, but also to the human homologue
                <sup>
                    <xref ref-type="bibr" rid="ref-40">40</xref>
                </sup>.</p>
            <p>In the tropics, HDM are important ubiquitous sources of protease allergens. Exposure is perennial, increasing the possibilities of exposure and IgE sensitization to their components in the general population
                <sup>
                    <xref ref-type="bibr" rid="ref-23">23</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-25">25</xref>
                </sup>. Sensitization to HDM group 3 allergens is common
                <sup>
                    <xref ref-type="bibr" rid="ref-26">26</xref>
                </sup>, and they harbor serine protease activity
                <sup>
                    <xref ref-type="bibr" rid="ref-27">27</xref>
                </sup>, a characteristic that make them highly allergenic. Moreover, their conserved structural homology makes them highly immunogenic
                <sup>
                    <xref ref-type="bibr" rid="ref-41">41</xref>,
                    <xref ref-type="bibr" rid="ref-42">42</xref>
                </sup> and suitable for epitope spreading
                <sup>
                    <xref ref-type="bibr" rid="ref-43">43</xref>
                </sup>. In this context, &#x201c;hit-and-run&#x201d; and epitope spreading establish framework mechanisms for environmental allergens with homology to autoantigens to potentially participate in the development of autoimmunity. We speculate that HDM group 3 allergens harbor two characteristics that make them suitable candidates for environmental triggering of AAV: their proteolytic activity that, as other protease allergens, set a tissue damaging microenvironment during antigen recognition
                <sup>
                    <xref ref-type="bibr" rid="ref-41">41</xref>
                </sup>; and molecular homology-epitope sharing with human PR3, that would elicit B cell autoantibody production and autoreactive T cell receptor generation. In conclusion, we observe that PR3 and HDM group 3 serine protease allergens have conserved identity, and for the first time we predict cross-reactive epitopes between them through an 
                <italic toggle="yes">in silico</italic> approach.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>UniProtKB: PRTN3_HUMAN, Accession number P24158: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P24158">https://www.uniprot.org/uniprot/P24158</ext-link>
            </p>
            <p>Protein Data Bank: PR3 (MYELOBLASTIN), Accession number 1FUJ: 
                <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1FUJ">https://www.rcsb.org/structure/1FUJ</ext-link>
            </p>
            <p>UniProtKB: Mite allergen Der p 3, Accession number P39675: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/P39675">https://www.uniprot.org/uniprot/P39675</ext-link>
            </p>
            <p>UniProtKB: Trypsin Blo t 3, Accession number A1KXI1: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/A1KXI1">https://www.uniprot.org/uniprot/A1KXI1</ext-link>
            </p>
            <p>UniProtKB: Gly d 3, Accession number Q1M2M8: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/Q1M2M8">https://www.uniprot.org/uniprot/Q1M2M8</ext-link>
            </p>
            <p>UniProtKB: Allergen Lep d 3, Accession number Q1M2L7: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/Q1M2L7">https://www.uniprot.org/uniprot/Q1M2L7</ext-link>
            </p>
            <p>UniProtKB: Trypsin Tyr p 3.0101, Accession number C6ZDB5: 
                <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprot/C6ZDB5">https://www.uniprot.org/uniprot/C6ZDB5</ext-link>
            </p>
        </sec>
    </body>
    <back>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jennette</surname>
                            <given-names>JC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Falk</surname>
                            <given-names>RJ</given-names>
                        </name>
</person-group>:
                    <article-title>Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.</article-title>
                    <source>

                        <italic toggle="yes">Nat Rev Rheumatol.</italic>
</source>
                    <year>2014</year>;<volume>10</volume>(<issue>8</issue>):<fpage>463</fpage>&#x2013;<lpage>73</lpage>.
                    <pub-id pub-id-type="pmid">25003769</pub-id>
                    <pub-id pub-id-type="doi">10.1038/nrrheum.2014.103</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wilde</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thewissen</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Damoiseaux</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?</article-title>
                    <source>

                        <italic toggle="yes">Arthritis Res Ther.</italic>
</source>
                    <year>2010</year>;<volume>12</volume>(<issue>1</issue>):<fpage>204</fpage>.
                    <pub-id pub-id-type="pmid">20236453</pub-id>
                    <pub-id pub-id-type="doi">10.1186/ar2923</pub-id>
                    <pub-id pub-id-type="pmcid">2875650</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>van der Geld</surname>
                            <given-names>YM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Huitema</surname>
                            <given-names>MG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Franssen</surname>
                            <given-names>CF</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>
                        <italic toggle="yes">In Vitro</italic> T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG).</article-title>
                    <source>

                        <italic toggle="yes">Clin Exp Immunol.</italic>
</source>
                    <year>2000</year>;<volume>122</volume>(<issue>3</issue>):<fpage>504</fpage>&#x2013;<lpage>13</lpage>.
                    <pub-id pub-id-type="pmid">11122262</pub-id>
                    <pub-id pub-id-type="doi">10.1046/j.1365-2249.2000.01415.x</pub-id>
                    <pub-id pub-id-type="pmcid">1905800</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hogan</surname>
                            <given-names>SL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Falk</surname>
                            <given-names>RJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chin</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.</article-title>
                    <source>

                        <italic toggle="yes">Ann Intern Med.</italic>
</source>
                    <year>2005</year>;<volume>143</volume>(<issue>9</issue>):<fpage>621</fpage>&#x2013;<lpage>31</lpage>.
                    <pub-id pub-id-type="pmid">16263884</pub-id>
                    <pub-id pub-id-type="doi">10.7326/0003-4819-143-9-200511010-00005</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>M&#x00fc;ller</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Voswinkel</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gottschlich</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses.</article-title>
                    <source>

                        <italic toggle="yes">Ann N Y Acad Sci.</italic>
</source>
                    <year>2007</year>;<volume>1109</volume>:<fpage>84</fpage>&#x2013;<lpage>92</lpage>.
                    <pub-id pub-id-type="pmid">17785293</pub-id>
                    <pub-id pub-id-type="doi">10.1196/annals.1398.010</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Specks</surname>
                            <given-names>U</given-names>
                        </name>
</person-group>:
                    <article-title>What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.</article-title>
                    <source>

                        <italic toggle="yes">Arthritis Res.</italic>
</source>
                    <year>2000</year>;<volume>2</volume>(<issue>4</issue>):<fpage>263</fpage>&#x2013;<lpage>7</lpage>.
                    <pub-id pub-id-type="pmid">11094439</pub-id>
                    <pub-id pub-id-type="doi">10.1186/ar99</pub-id>
                    <pub-id pub-id-type="pmcid">130016</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Falk</surname>
                            <given-names>RJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Terrell</surname>
                            <given-names>RS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Charles</surname>
                            <given-names>LA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals 
                        <italic toggle="yes">In Vitro</italic>.</article-title>
                    <source>

                        <italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
</source>
                    <year>1990</year>;<volume>87</volume>(<issue>11</issue>):<fpage>4115</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">2161532</pub-id>
                    <pub-id pub-id-type="doi">10.1073/pnas.87.11.4115</pub-id>
                    <pub-id pub-id-type="pmcid">54058</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Xiao</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heeringa</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hu</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.</article-title>
                    <source>

                        <italic toggle="yes">J Clin Invest.</italic>
</source>
                    <year>2002</year>;<volume>110</volume>(<issue>7</issue>):<fpage>955</fpage>&#x2013;<lpage>63</lpage>.
                    <pub-id pub-id-type="pmid">12370273</pub-id>
                    <pub-id pub-id-type="doi">10.1172/JCI15918</pub-id>
                    <pub-id pub-id-type="pmcid">151154 </pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Benoist</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mathis</surname>
                            <given-names>D</given-names>
                        </name>
</person-group>:
                    <article-title>Autoimmunity. The pathogen connection.</article-title>
                    <source>

                        <italic toggle="yes">Nature.</italic>
</source>
                    <year>1998</year>;<volume>394</volume>(<issue>6690</issue>):<fpage>227</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">9685154</pub-id>
                    <pub-id pub-id-type="doi">10.1038/28282</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rojas</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Restrepo-Jim&#x00e9;nez</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Monsalve</surname>
                            <given-names>DM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Molecular mimicry and autoimmunity.</article-title>
                    <source>

                        <italic toggle="yes">J Autoimmun.</italic>
</source>
                    <year>2018</year>;<volume>95</volume>:<fpage>100</fpage>&#x2013;<lpage>23</lpage>.
                    <pub-id pub-id-type="pmid">30509385</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaut.2018.10.012</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pendergraft</surname>
                            <given-names>WF</given-names>
                            <suffix>3rd</suffix>
                        </name>

                        <name name-style="western">
                            <surname>Preston</surname>
                            <given-names>GA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shah</surname>
                            <given-names>RR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.</article-title>
                    <source>

                        <italic toggle="yes">Nat Med.</italic>
</source>
                    <year>2004</year>;<volume>10</volume>(<issue>1</issue>):<fpage>72</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">14661018</pub-id>
                    <pub-id pub-id-type="doi">10.1038/nm968</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fujinaga</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chernaia</surname>
                            <given-names>MM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Halenbeck</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The Crystal Structure of PR3, a Neutrophil Serine Proteinase Antigen of Wegener's Granulomatosis Antibodies.</article-title>
                    <source>

                        <italic toggle="yes">J Mol Biol.</italic>
</source>
                    <year>1996</year>;<volume>261</volume>(<issue>2</issue>):<fpage>267</fpage>&#x2013;<lpage>78</lpage>.
                    <pub-id pub-id-type="pmid">8757293</pub-id>
                    <pub-id pub-id-type="doi">10.1006/jmbi.1996.0458</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bruner</surname>
                            <given-names>BF</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vista</surname>
                            <given-names>ES</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wynn</surname>
                            <given-names>DM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener&#x2019;s granulomatosis.</article-title>
                    <source>

                        <italic toggle="yes">Clin Exp Immunol.</italic>
</source>
                    <year>2010</year>;<volume>162</volume>(<issue>2</issue>):<fpage>262</fpage>&#x2013;<lpage>70</lpage>.
                    <pub-id pub-id-type="pmid">21077276</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04251.x</pub-id>
                    <pub-id pub-id-type="pmcid">2996593</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kuhl</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Korkmaz</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Utecht</surname>
                            <given-names>B</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis.</article-title>
                    <source>

                        <italic toggle="yes">J Immunol.</italic>
</source>
                    <year>2010</year>;<volume>185</volume>(<issue>1</issue>):<fpage>387</fpage>&#x2013;<lpage>99</lpage>.
                    <pub-id pub-id-type="pmid">20530264</pub-id>
                    <pub-id pub-id-type="doi">10.4049/jimmunol.0903887</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hasni</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gupta</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Davis</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.</article-title>
                    <source>

                        <italic toggle="yes">Arthritis Rheumatol.</italic>
</source>
                    <year>2019</year>;<volume>71</volume>(<issue>7</issue>):<fpage>1135</fpage>&#x2013;<lpage>40</lpage>.
                    <pub-id pub-id-type="pmid">30597768</pub-id>
                    <pub-id pub-id-type="doi">10.1002/art.40828</pub-id>
                    <pub-id pub-id-type="pmcid">6594871</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Glaser</surname>
                            <given-names>AG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Menz</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kirsch</surname>
                            <given-names>AI</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Auto- and cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis.</article-title>
                    <source>

                        <italic toggle="yes">Allergy.</italic>
</source>
                    <year>2008</year>;<volume>63</volume>(<issue>12</issue>):<fpage>1617</fpage>&#x2013;<lpage>23</lpage>.
                    <pub-id pub-id-type="pmid">19032234</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2008.01777.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Roesner</surname>
                            <given-names>LM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heratizadeh</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wieschowski</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>&#x03b1;-NAC-Specific Autoreactive CD8
                        <sup>+</sup> T Cells in Atopic Dermatitis Are of an Effector Memory Type and Secrete IL-4 and IFN-&#x03b3;.</article-title>
                    <source>

                        <italic toggle="yes">J Immunol.</italic>
</source>
                    <year>2016</year>;<volume>196</volume>(<issue>8</issue>):<fpage>3245</fpage>&#x2013;<lpage>52</lpage>.
                    <pub-id pub-id-type="pmid">26962231</pub-id>
                    <pub-id pub-id-type="doi">10.4049/jimmunol.1500351</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>S&#x00e1;nchez</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>S&#x00e1;nchez</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cardona</surname>
                            <given-names>R</given-names>
                        </name>
</person-group>:
                    <article-title>Causal Relationship Between Anti-TPO IgE and Chronic Urticaria by 
                        <italic toggle="yes">In Vitro</italic> and 
                        <italic toggle="yes">In Vivo</italic> Tests.</article-title>
                    <source>

                        <italic toggle="yes">Allergy Asthma Immunol Res.</italic>
</source>
                    <year>2019</year>;<volume>11</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>42</lpage>.
                    <pub-id pub-id-type="pmid">30479075</pub-id>
                    <pub-id pub-id-type="doi">10.4168/aair.2019.11.1.29</pub-id>
                    <pub-id pub-id-type="pmcid">6267185</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Qian</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jeong</surname>
                            <given-names>JS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Maldonado</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cutting Edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen.</article-title>
                    <source>

                        <italic toggle="yes">J Immunol.</italic>
</source>
                    <year>2012</year>;<volume>189</volume>(<issue>4</issue>):<fpage>1535</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">22798673</pub-id>
                    <pub-id pub-id-type="doi">10.4049/jimmunol.1200842</pub-id>
                    <pub-id pub-id-type="pmcid">3411885</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Roesner</surname>
                            <given-names>LM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ernst</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Human thioredoxin, a damage-associated molecular pattern and 
                        <italic toggle="yes">Malassezia</italic>-crossreactive autoallergen, modulates immune responses via the C-type lectin receptors Dectin-1 and Dectin-2.</article-title>
                    <source>

                        <italic toggle="yes">Sci Rep.</italic>
</source>
                    <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>11210</fpage>.
                    <pub-id pub-id-type="pmid">31371767</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41598-019-47769-2</pub-id>
                    <pub-id pub-id-type="pmcid">6671947</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Balaji</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Heratizadeh</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wichmann</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>
                        <italic toggle="yes">Malassezia sympodialis</italic> thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis.</article-title>
                    <source>

                        <italic toggle="yes">J Allergy Clin Immunol.</italic>
</source>
                    <year>2011</year>;<volume>128</volume>(<issue>1</issue>):<fpage>92</fpage>&#x2013;<lpage>9.e4</lpage>.
                    <pub-id pub-id-type="pmid">21489611</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2011.02.043</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lin</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Moran</surname>
                            <given-names>TP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Peng</surname>
                            <given-names>B</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a "hit-and-run" mechanism.</article-title>
                    <source>

                        <italic toggle="yes">J Allergy Clin Immunol.</italic>
</source>
                    <year>2019</year>;<volume>144</volume>(<issue>3</issue>):<fpage>720</fpage>&#x2013;<lpage>8.e4</lpage>.
                    <pub-id pub-id-type="pmid">31071340</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2019.04.020</pub-id>
                    <pub-id pub-id-type="pmcid">6742533</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Acevedo</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zakzuk</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Caraballo</surname>
                            <given-names>L</given-names>
                        </name>
</person-group>:
                    <article-title>House Dust Mite Allergy Under Changing Environments.</article-title>
                    <source>

                        <italic toggle="yes">Allergy Asthma Immunol Res.</italic>
</source>
                    <year>2019</year>;<volume>11</volume>(<issue>4</issue>):<fpage>450</fpage>&#x2013;<lpage>69</lpage>.
                    <pub-id pub-id-type="pmid">31172715</pub-id>
                    <pub-id pub-id-type="doi">10.4168/aair.2019.11.4.450</pub-id>
                    <pub-id pub-id-type="pmcid">6557771</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-24">
                <label>24</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Zakzuk</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mercado</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bornacelly</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Hygienic conditions influence sensitization to 
                        <italic toggle="yes">Blomia tropicalis</italic> allergenic components: Results from the FRAAT birth cohort.</article-title>
                    <source>

                        <italic toggle="yes">Pediatr Allergy Immunol.</italic>
</source>
                    <year>2019</year>;<volume>30</volume>(<issue>2</issue>):<fpage>172</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">30421833</pub-id>
                    <pub-id pub-id-type="doi">10.1111/pai.13004</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Acevedo</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>S&#x00e1;nchez</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zakzuk</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Particular characteristics of allergic symptoms in tropical environments: follow up to 24 months in the FRAAT birth cohort study.</article-title>
                    <source>

                        <italic toggle="yes">BMC Pulm Med.</italic>
</source>
                    <year>2012</year>;<volume>12</volume>:<fpage>13</fpage>.
                    <pub-id pub-id-type="pmid">22439773</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1471-2466-12-13</pub-id>
                    <pub-id pub-id-type="pmcid">3331807</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>S&#x00e1;nchez-Borges</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fernandez-Caldas</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thomas</surname>
                            <given-names>WR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.</article-title>
                    <source>

                        <italic toggle="yes">World Allergy Organ J.</italic>
</source>
                    <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<fpage>14</fpage>.
                    <pub-id pub-id-type="pmid">28451053</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s40413-017-0145-4</pub-id>
                    <pub-id pub-id-type="pmcid">5394630</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Stewart</surname>
                            <given-names>GA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ward</surname>
                            <given-names>LD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Simpson</surname>
                            <given-names>RJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The group III allergen from the house dust mite Dermatophagoides pteronyssinus is a trypsin-like enzyme.</article-title>
                    <source>

                        <italic toggle="yes">Immunology.</italic>
</source>
                    <year>1992</year>;<volume>75</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>35</lpage>.
                    <pub-id pub-id-type="pmid">1537598</pub-id>
                    <pub-id pub-id-type="pmcid">1384798</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Clamp</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cuff</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Searle</surname>
                            <given-names>SM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The Jalview Java alignment editor.</article-title>
                    <source>

                        <italic toggle="yes">Bioinformatics.</italic>
</source>
                    <year>2004</year>;<volume>20</volume>(<issue>3</issue>):<fpage>426</fpage>&#x2013;<lpage>7</lpage>.
                    <pub-id pub-id-type="pmid">14960472</pub-id>
                    <pub-id pub-id-type="doi">10.1093/bioinformatics/btg430</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-29">
                <label>29</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wiederstein</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sippl</surname>
                            <given-names>MJ</given-names>
                        </name>
</person-group>:
                    <article-title>ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2007</year>;<volume>35</volume>(<issue>Web Server issue</issue>):<fpage>W407</fpage>&#x2013;<lpage>10</lpage>.
                    <pub-id pub-id-type="pmid">17517781</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkm290</pub-id>
                    <pub-id pub-id-type="pmcid">1933241</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-30">
                <label>30</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pettersen</surname>
                            <given-names>EF</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Goddard</surname>
                            <given-names>TD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Huang</surname>
                            <given-names>CC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>UCSF Chimera--a visualization system for exploratory research and analysis.</article-title>
                    <source>

                        <italic toggle="yes">J Comput Chem.</italic>
</source>
                    <year>2004</year>;<volume>25</volume>(<issue>13</issue>):<fpage>1605</fpage>&#x2013;<lpage>12</lpage>.
                    <pub-id pub-id-type="pmid">15264254</pub-id>
                    <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-31">
                <label>31</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ponomarenko</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bui</surname>
                            <given-names>HH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>ElliPro: a new structure-based tool for the prediction of antibody epitopes.</article-title>
                    <source>

                        <italic toggle="yes">BMC Bioinformatics.</italic>
</source>
                    <year>2008</year>;<volume>9</volume>:<fpage>514</fpage>.
                    <pub-id pub-id-type="pmid">19055730</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1471-2105-9-514</pub-id>
                    <pub-id pub-id-type="pmcid">2607291</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-32">
                <label>32</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jespersen</surname>
                            <given-names>MC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Peters</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nielsen</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2017</year>;<volume>45</volume>(<issue>W1</issue>):<fpage>W24</fpage>&#x2013;<lpage>w9</lpage>.
                    <pub-id pub-id-type="pmid">28472356</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkx346</pub-id>
                    <pub-id pub-id-type="pmcid">5570230</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-33">
                <label>33</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pendergraft</surname>
                            <given-names>WF</given-names>
                            <suffix>3rd</suffix>
                        </name>

                        <name name-style="western">
                            <surname>Pressler</surname>
                            <given-names>BM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jennette</surname>
                            <given-names>JC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.</article-title>
                    <source>

                        <italic toggle="yes">J Mol Med (Berl).</italic>
</source>
                    <year>2005</year>;<volume>83</volume>(<issue>1</issue>):<fpage>12</fpage>&#x2013;<lpage>25</lpage>.
                    <pub-id pub-id-type="pmid">15592920</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00109-004-0615-3</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-34">
                <label>34</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tadema</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kallenberg</surname>
                            <given-names>CG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Stegeman</surname>
                            <given-names>CA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2011</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e17972</fpage>.
                    <pub-id pub-id-type="pmid">21437233</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0017972</pub-id>
                    <pub-id pub-id-type="pmcid">3060099</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-35">
                <label>35</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hewins</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Belmonte</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Charles Jennette</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N.</article-title>
                    <source>

                        <italic toggle="yes">Autoimmunity.</italic>
</source>
                    <year>2011</year>;<volume>44</volume>(<issue>2</issue>):<fpage>98</fpage>&#x2013;<lpage>106</lpage>.
                    <pub-id pub-id-type="pmid">20712431</pub-id>
                    <pub-id pub-id-type="doi">10.3109/08916934.2010.491843</pub-id>
                    <pub-id pub-id-type="pmcid">3016444</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-36">
                <label>36</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yang</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bautz</surname>
                            <given-names>DJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lionaki</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>ANCA patients have T cells responsive to complementary PR-3 antigen.</article-title>
                    <source>

                        <italic toggle="yes">Kidney Int.</italic>
</source>
                    <year>2008</year>;<volume>74</volume>(<issue>9</issue>):<fpage>1159</fpage>&#x2013;<lpage>69</lpage>.
                    <pub-id pub-id-type="pmid">18596726</pub-id>
                    <pub-id pub-id-type="doi">10.1038/ki.2008.309</pub-id>
                    <pub-id pub-id-type="pmcid">2754720</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-37">
                <label>37</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mezzano</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Valderrama</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Olavarria</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antineutrophil-cytoplasmic-autoantibodies in poststreptococcal nephritis.</article-title>
                    <source>

                        <italic toggle="yes">Adv Exp Med Biol.</italic>
</source>
                    <year>1993</year>;<volume>336</volume>:<fpage>449</fpage>&#x2013;<lpage>53</lpage>.
                    <pub-id pub-id-type="pmid">8296654</pub-id>
                    <pub-id pub-id-type="doi">10.1007/978-1-4757-9182-2_80</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-38">
                <label>38</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hellmich</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ehren</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lindstaedt</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis.</article-title>
                    <source>

                        <italic toggle="yes">Clin Rheumatol.</italic>
</source>
                    <year>2001</year>;<volume>20</volume>(<issue>6</issue>):<fpage>441</fpage>&#x2013;<lpage>3</lpage>.
                    <pub-id pub-id-type="pmid">11771532</pub-id>
                    <pub-id pub-id-type="doi">10.1007/pl00011214</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-39">
                <label>39</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pudifin</surname>
                            <given-names>DJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Duursma</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gathiram</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody.</article-title>
                    <source>

                        <italic toggle="yes">Clin Exp Immunol.</italic>
</source>
                    <year>1994</year>;<volume>97</volume>(<issue>1</issue>):<fpage>48</fpage>&#x2013;<lpage>51</lpage>.
                    <pub-id pub-id-type="pmid">8033420</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1365-2249.1994.tb06578.x</pub-id>
                    <pub-id pub-id-type="pmcid">1534777</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-40">
                <label>40</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Valenta</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Duch&#x00ea;ne</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pettenburger</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals.</article-title>
                    <source>

                        <italic toggle="yes">Science.</italic>
</source>
                    <year>1991</year>;<volume>253</volume>(<issue>5019</issue>):<fpage>557</fpage>&#x2013;<lpage>60</lpage>.
                    <pub-id pub-id-type="pmid">1857985</pub-id>
                    <pub-id pub-id-type="doi">10.1126/science.1857985</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-41">
                <label>41</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cayrol</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Duval</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schmitt</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33.</article-title>
                    <source>

                        <italic toggle="yes">Nat Immunol.</italic>
</source>
                    <year>2018</year>;<volume>19</volume>(<issue>4</issue>):<fpage>375</fpage>&#x2013;<lpage>85</lpage>.
                    <pub-id pub-id-type="pmid">29556000</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41590-018-0067-5</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-42">
                <label>42</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Westernberg</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schulten</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Greenbaum</surname>
                            <given-names>JA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>T-cell epitope conservation across allergen species is a major determinant of immunogenicity.</article-title>
                    <source>

                        <italic toggle="yes">J Allergy Clin Immunol.</italic>
</source>
                    <year>2016</year>;<volume>138</volume>(<issue>2</issue>):<fpage>571</fpage>&#x2013;<lpage>8.e7</lpage>.
                    <pub-id pub-id-type="pmid">26883464</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2015.11.034</pub-id>
                    <pub-id pub-id-type="pmcid">4975972</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-43">
                <label>43</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Burastero</surname>
                            <given-names>SE</given-names>
                        </name>
</person-group>:
                    <article-title>T-cell receptor-mediated cross-reactivity to different allergens is driven by recognition of homologous, phylogenetically conserved epitopes.</article-title>
                    <source>

                        <italic toggle="yes">J Allergy Clin Immunol.</italic>
</source>
                    <year>2016</year>;<volume>138</volume>(<issue>4</issue>):<fpage>1237</fpage>.
                    <pub-id pub-id-type="pmid">27484036</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.055</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report136303">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.81402.r136303</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Tanaka</surname>
                        <given-names>Hiroshi</given-names>
                    </name>
                    <xref ref-type="aff" rid="r136303a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7057-813X</uri>
                </contrib>
                <aff id="r136303a1">
                    <label>1</label>Department of School Health Science, Hirosaki University Hospital, Hirosaki, Japan</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>5</month>
                <year>2022</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Tanaka H</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport136303" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.28225.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>To elucidate the origin of the autoreactive response of human proteinase 3 (PR3), the authors examined molecular similarity between environmental antigens and PR3. They found that some house dust mites showed structural homology to PR3. Some environmental antigens, such as house dust mites, may be attributable to the production of PR3-ANCA.</p>
            <p> </p>
            <p> This is an interesting paper. The results obtained is informative enough for readers.</p>
            <p> It is nice to add some comments or speculation about how the results obtained are relevant in real-world clinical practice, particularly the etiology and treatment of patients with C-ANCA-related vasculitis. This issue is very relevant for physicians who treat patients with ANCA-related vasculitis.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Not applicable</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Nephrology, Rheumatology, Clinical immunology, Pediatrics</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report124319">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.81402.r124319</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Erban</surname>
                        <given-names>Tomas</given-names>
                    </name>
                    <xref ref-type="aff" rid="r124319a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-1730-779X</uri>
                </contrib>
                <aff id="r124319a1">
                    <label>1</label>Crop Research Institute, Prague, Czech Republic</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>29</day>
                <month>3</month>
                <year>2022</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Erban T</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport124319" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.28225.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Buendia et al. investigated in their manuscript possible link between human proteinase 3 (PR3) and house dust mite allergen protease that is denoted as allergen group 3. Authors suggest that similarity between PR3 and the group 3 mite allergens may be link to autoimmune vasculitis. Methodology and conclusions are based on structural homology based on in silico analysis. I believe that recommendations will improve the manuscript, which is of interest.</p>
            <p> </p>
            <p> Because methodology of the study is based on in silico tools, it is necessary to consider that the function is &#x201c;possible&#x201d; and needs to be confirmed in future.&#x00a0;</p>
            <p> </p>
            <p> Please note, that group 3 mite allergens become subject of debate in the domestic mites, that include both hose dust (HDMs) and stored product mite (SPMs) species. Immortally, authors should clarify that allergens of HDMs and SPMs were included in the study. In addition, these allergens are present in mite feces and, therefore, they are abundant in the environment. Thus, introduction should be improved.</p>
            <p> </p>
            <p> It was found that occurrence of trypsin allergens in mites differs in species and strains. The expression of group 3 mite allergens was observed to be affected by presence of intracellular symbionts in mites. There is suggested link to PAR2 (PAR-2) in mites (&#x2013; for instance, see: https://doi.org/10.1016/j.jprot.2021.104356
                <sup>
                    <xref ref-type="bibr" rid="rep-ref-124319-1">1</xref>
                </sup>). The affected pathway in mites can be affected also in humans. Could be a suggested link to PR3 in this regard? e.g. &#x201c;immune functions of PR3 with respect to PR3 modulation of cell activation via cleavage of protease-activated receptor-2 (PAR-2)&#x201d; - Ann N Y Acad Sci. 2007 Aug;1109:84-92. doi: 10.1196/annals.1398.010
                <sup>
                    <xref ref-type="bibr" rid="rep-ref-124319-2">2</xref>
                </sup>.</p>
            <p> Authors can also consider the suggested &#x201c;Orchestration of an uncommon maturation cascade of the house dust mite protease allergen quartet&#x201d; (https://doi.org/10.3389/fimmu.2014.00138
                <sup>
                    <xref ref-type="bibr" rid="rep-ref-124319-3">3</xref>
                </sup>)</p>
            <p> </p>
            <p> Comment to approach&#x00a0; 
                <list list-type="bullet">
                    <list-item>
                        <p>Authors used different sequences of group 3 mite allergens to predict similarity. It should be clear whether &#x201c;pro&#x201d; or mature form was used in analyses. It is recommended that authors will consider change &#x201c;identity&#x201d; to similarity. Usually, high identity is &#x201c;only&#x201d; to partial sequence. It is important to consider overall similarity.</p>
                    </list-item>
                    <list-item>
                        <p>In initial stage, authors used multiple Grp3 sequences, i.e.: Der p 3, Blo t 3, Gly d 3, Led p 3 and Tyr p 3. Is it possible to report similarity?&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>In further analysis, authors used Der p 3 sequence. Incidentally, research showed that D. pteronyssinus is depleted of this allergen in mite feces, although it is high-abundance in D. farinae &#x2013; for instance, see J Proteomics. 2017 Jun 6;162:11-19 &#x00a0;doi: 10.1016/j.jprot.2017.04.021
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-124319-4">4</xref>
                            </sup>
                        </p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Invertebrate physiology, proteomics, acarology, allergens, multiomics</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-124319-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Label-free proteomic analysis reveals differentially expressed Wolbachia proteins in Tyrophagus putrescentiae: Mite allergens and markers reflecting population-related proteome differences</article-title>.
                        <source>
                            <italic>Journal of Proteomics</italic>
                        </source>.<year>2021</year>;<volume>249</volume>:
                        <elocation-id>10.1016/j.jprot.2021.104356</elocation-id>
                        <pub-id pub-id-type="doi">10.1016/j.jprot.2021.104356</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-124319-2">
                    <label>2</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses.</article-title>
                        <source>
                            <italic>Ann N Y Acad Sci</italic>
                        </source>.<year>2007</year>;<volume>1109</volume>:
                        <elocation-id>10.1196/annals.1398.010</elocation-id>
                        <fpage>84</fpage>-<lpage>92</lpage>
                        <pub-id pub-id-type="pmid">17785293</pub-id>
                        <pub-id pub-id-type="doi">10.1196/annals.1398.010</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-124319-3">
                    <label>3</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Orchestration of an uncommon maturation cascade of the house dust mite protease allergen quartet.</article-title>
                        <source>
                            <italic>Front Immunol</italic>
                        </source>.<year>2014</year>;<volume>5</volume>:
                        <elocation-id>10.3389/fimmu.2014.00138</elocation-id>
                        <fpage>138</fpage>
                        <pub-id pub-id-type="pmid">24744761</pub-id>
                        <pub-id pub-id-type="doi">10.3389/fimmu.2014.00138</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-124319-4">
                    <label>4</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Detailed two-dimensional gel proteomic mapping of the feces of the house dust mite Dermatophagoides pteronyssinus and comparison with D. farinae : Reduced trypsin protease content in D. pteronyssinus and different isoforms</article-title>.
                        <source>
                            <italic>Journal of Proteomics</italic>
                        </source>.<year>2017</year>;<volume>162</volume>:
                        <elocation-id>10.1016/j.jprot.2017.04.021</elocation-id>
                        <fpage>11</fpage>-<lpage>19</lpage>
                        <pub-id pub-id-type="doi">10.1016/j.jprot.2017.04.021</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report90330">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.31220.r90330</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Selvaraj</surname>
                        <given-names>Chandrabose</given-names>
                    </name>
                    <xref ref-type="aff" rid="r90330a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-8115-0486</uri>
                </contrib>
                <aff id="r90330a1">
                    <label>1</label>Department of Bioinformatics, Computer Aided Drug Design and Molecular Modeling Lab, Alagappa University, Karaikudi, Tamilnadu, 630003, India</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>9</day>
                <month>8</month>
                <year>2021</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Selvaraj C</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport90330" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.28225.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Reviewer Recommendation: Major Revision 
                <list list-type="order">
                    <list-item>
                        <p>Primary check on this manuscript for language refinement is mandatory as I see that it is not satisfactory, and moreover, there are more typographical errors. I suggest the authors go with language and grammar checks.</p>
                    </list-item>
                    <list-item>
                        <p>The following sentence seems incomplete and difficult to understand, reframe it&#x00a0;&#x201c;Here, allergens such as: Der p 3, Blo t 3, Gly d 3, Led p 3 and Tyr p 3 shared an identity of 45% among them according to multiple sequence alignment"</p>
                    </list-item>
                    <list-item>
                        <p>Why have authors selected PR-3 for the homologous evaluation study? Since the 3-D structure is available in the PDB database?</p>
                    </list-item>
                    <list-item>
                        <p>What basis authors have selected allergenic sources such as Dermatophagoides pteronyssinus (Der p 3: Accession number P39675), Blomia tropicalis (Blo t 3: A1KXI1), Glycyphagus domesticus (Gly d 3: Q1M2M8), Lepidoglyphus destructor (Led p 3: Q1M2L7) and Tyrophagus putrescentiae (Tyr p 3:C6ZDB5) in this study? In BLAST it did not show the above mentioned allergens.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>Did authors find the sequence similarity analysis of target sequence Der p 3 with its template; if so provide that information more in detail.</p>
                    </list-item>
                    <list-item>
                        <p>Swiss-Modeler does not show the 1FUJ as template in template searching, and then what basis authors have checked RMSD calculation between the modeled structure and IFUJ as template?</p>
                    </list-item>
                    <list-item>
                        <p>In methodology part authors have mentioned that the modeled structure was subjected to validation, but lack results and interpretation. Provide more in detail.</p>
                    </list-item>
                    <list-item>
                        <p>Provide abbreviation for AAV</p>
                    </list-item>
                    <list-item>
                        <p>Is the residues present in the epitope region responsible for the antigenic effect?</p>
                    </list-item>
                    <list-item>
                        <p>In epitope prediction, the author only provides the sequence and length of the epitopes, if the author provides the information on score value, identity and whether it is present in any domain or motif it could be more informative.&#x00a0;</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>No</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Partly</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>Immunoinformatics, Computational Biology, Molecular Modeling</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment7564-90330">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Buend&#x00ed;a</surname>
                            <given-names>Emiro</given-names>
                        </name>
                        <aff>Universidad del Norte, Colombia, Colombia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>10</day>
                    <month>12</month>
                    <year>2021</year>
                </pub-date>
            </front-stub>
            <body>
                <p>
                    <bold>Emiro Buend&#x00ed;a, </bold>Division of Health Sciences, Universidad del Norte, Barranquilla, Colombia.</p>
                <p> </p>
                <p> Dear reviewer, thanks for the reading of the paper, we have taken note of all your comments, questions and suggestions. Our responses are bellow:</p>
                <p> </p>
                <p> 
                    <bold>1. Reviewer:</bold> Primary check on this manuscript for language refinement is mandatory as I see that it is not satisfactory, and moreover, there are more typographical errors. I suggest the authors go with language and grammar checks.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your suggestion. The manuscript was revised and refined by a language style corrector.</p>
                <p> </p>
                <p> 
                    <bold>2. Reviewer:</bold> The following sentence seems incomplete and difficult to understand, reframe it &#x201c;Here, allergens such as: Der p 3, Blo t 3, Gly d 3, Led p 3 and Tyr p 3 shared an identity of 45% among them according to multiple sequence alignment"</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your suggestion. A new sentence was added: &#x201c;Multiple sequence alignment showed that Der p 3, Blo t 3, Gly d 3, Led p 3 and Tyr p 3 allergens shared 45% of identity in their aminoacid sequences with PR3. The most conserved region is located between residues 53 to 75, indicating the existence of molecular mimicry.&#x201d;</p>
                <p> </p>
                <p> 
                    <bold>3. Reviewer:</bold> Why have authors selected PR-3 for the homologous evaluation study? Since the 3-D structure is available in the PDB database?</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your question. We selected PR3 for the study because it is the most important autoantigen in ANCA + vasculitis. Since, this human protein is a serine protease, in the sequence alignment analysis we seek for other serine proteases in mites, because it is a previously described environmentally ubiquitous serine protease source. In our study we selected the 3D model of PR3 from the Protein Data Bank as mentioned in your observation because its structure was already deciphered, the structural homology analysis was done keeping in mind that its serine protease folding could make more possible for us to model homologous serine in mites.</p>
                <p> </p>
                <p> 
                    <bold>4. Reviewer:</bold> What basis authors have selected allergenic sources such as Dermatophagoides pteronyssinus (Der p 3: Accession number P39675), Blomia tropicalis (Blo t 3: A1KXI1), Glycyphagus domesticus (Gly d 3: Q1M2M8), Lepidoglyphus destructor (Led p 3: Q1M2L7) and Tyrophagus putrescentiae (Tyr p 3:C6ZDB5) in this study? In BLAST it did not show the above-mentioned allergens.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your question. These allergens were chosen on the basis that they belong to the serine protease family, and our hypothesis was that the sensitization to these allergens is cross-reactive with the PR3 autoantigen. So, search was limited using terms: American house dust mite (taxid:6954). In this way, results were only about mites, an important allergenic source.</p>
                <p> </p>
                <p> 
                    <bold>5. Reviewer:</bold> Did authors find the sequence similarity analysis of target sequence Der p 3 with its template; if so provide that information more in detail.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your question. Yes, the binary alignment showed 33% identity between the template amino acid sequences, and Der p 3. An image of the alignment was uploaded in the new manuscript version.</p>
                <p> </p>
                <p> 
                    <bold>6. Reviewer:</bold> Swiss-Modeler does not show the 1FUJ as template in template searching, and then what basis authors have checked RMSD calculation between the modeled structure and IFUJ as template?</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your question. For modelling the mite allergen Der p 3 structure, we used the zymogen catalytic region of MASP-2, a lectin binding mannose from human (PDB: 1zjk f), as a template because 1FUJ code was not listed in Swiss-Modeler query results for this protein. Next we calculated the RMSD based on the predicted structure of the mite Der p3 protease and the previously resolved structure of&#x00a0; the human PR3. The following sentence was improved to answer your question in the method section of the paper (
                    <bold>Construction of 3D model</bold>): &#x201c;The 3D model of Der p 3, a serine protease of 
                    <italic>Dermatophagoides pteronyssinus</italic> was generated by homology in the 
                    <ext-link ext-link-type="uri" xlink:href="https://swissmodel.expasy.org/">SWISS-MODEL</ext-link> server using the zymogen catalytic region of human MASP-2 (PDB: 1zjk f) as a template. The 3D model of Der p 3 was loaded into the ProSA-web server 
                    <sup>29</sup>
                    <sup> </sup>, which was used to analyze its quality&#x201d;.</p>
                <p> </p>
                <p> 
                    <bold>7. Reviewer:</bold> In methodology part authors have mentioned that the modeled structure was subjected to validation, but lack results and interpretation. Provide more in detail.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your suggestion. We added the next sentence in the method section (
                    <bold>Construction of 3D model</bold>): For the validation of the Der p 3 structure we used the Minimize Structure option in the UCSF Chimera software, a procedure that adjust the energy (entropy) of the model.&#x00a0;</p>
                <p> </p>
                <p> 
                    <bold>8. Reviewer:</bold> Provide abbreviation for AAV.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your suggestion. ANCA Associated Vasculitis (AAV) was included in the corrected paper text.</p>
                <p> </p>
                <p> 
                    <bold>9. Reviewer:</bold> Is the residues present in the epitope region responsible for the antigenic effect?</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your question. We think that the residues found in the epitope region are involved in the cross reactivity between the studied serine protease and hypothesized have a role in autoimmunity inception. But this are preliminary results awaiting experimental validation.&#x00a0;</p>
                <p> </p>
                <p> 
                    <bold>10. Reviewer:</bold> In epitope prediction, the author only provides the sequence and length of the epitopes, if the author provides the information on score value, identity and whether it is present in any domain or motif it could be more informative.&#x00a0;</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> We appreciate your suggestion. The B epitope is part of the N-terminal region of PR3 and is not within any domain of the protein. The T epitope spanned between residues 45-59 is located on the first and second beta lamina. While the second epitope T (63-77) is located in the third beta sheet, and first alpha helix in the protein structure. In the result section (
                    <bold>T and B cell cross-reactive epitopes were predicted between HDM group 3 allergens and PR3</bold>
                    <bold>), </bold>two sentences were improved to consider your suggestion.</p>
            </body>
        </sub-article>
    </sub-article>
</article>
